U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Sustained release pharmaceutical preparations containing an analgesic and a decongestant

Patent 5085865 Issued on February 4, 1992. Estimated Expiration Date: Icon_subject April 12, 2009. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

3567819

Pharmaceutical compositions
Patent #: 4189469
Issued on: 02/19/1980
Inventor: Gleixner ,   et al.

Method and preparation for administration to the mucosa of the oral or nasal cavity
Patent #: 4226848
Issued on: 10/07/1980
Inventor: Nagai ,   et al.

Method and preparation for administration to the mucosa of the oral or nasal cavity
Patent #: 4250163
Issued on: 02/10/1981
Inventor: Nagai ,   et al.

Edible unit dosage form consisting of outer mannitol shell and inner liquid or gel center and method for manufacturing the same
Patent #: 4260596
Issued on: 04/07/1981
Inventor: Mackles

Thixotropic compositions easily convertible to pourable liquids
Patent #: 4427681
Issued on: 01/24/1984
Inventor: Munshi

Simultaneous delivery of two drugs from unit delivery device
Patent #: 4449983
Issued on: 05/22/1984
Inventor: Cortese ,   et al.

Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
Patent #: 4601894
Issued on: 07/22/1986
Inventor: Hanna ,   et al.

Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
Patent #: 4657757
Issued on: 04/14/1987
Inventor: Hanna ,   et al.

Sustained release dosage form based on highly plasticized cellulose ether gels
Patent #: 4678516
Issued on: 07/07/1987
Inventor: Alderman ,   et al.

More ...

Inventor

Application

No. 336929 filed on 04/12/1989

US Classes:

424/472, Layered unitary dosage forms424/465, With claimed perfecting feature in contents (e.g., excipient, lubricant, etc.)424/468, Sustained or differential release type424/469, Discrete particles in supporting matrix424/470, Where particles are granulated424/480, Cellulose or derivative514/853DECONGESTANT

Examiners

Primary: Page, Thurman K.
Assistant: Spear, James M.

Attorney, Agent or Firm

Foreign Patent References

  • 0111144 A EP. 06/13/1984
  • 8808299 WO. 11/13/1988
  • 874580 GB. 08/13/1961
  • 1334732 GB. 10/13/1973
  • 1551698 GB. 08/13/1979
  • 2123291 GB. 02/13/1984

International Classes

A61K 009/22
A61K 009/24

Abstract

An orally administrable sustained-release pharmaceutical tablet having at least two layers, which are directly compressible, is disclosed. The first layer, an immediate-release layer, contains an orally active analgesic and is readily susceptible to disintegration in the stomach. The second layer, a sustained-release layer which is directly compressed onto the first layer, comprises an orally active decongestant admixed with a major amount of a sustained-release agent so as to display increased resistance to disintegration and erosion in the gastro-intestinal tract relative to the first layer.

Other References

  • The Theory and Practice of Industrial Pharmacy, 2nd Ed., Lea & Febiger, Phil. U.S.A., 1976, pp. 343, 344
  • Formulating For Controlled Release with METHOCEL Cellulose Ethers, Form No. 192-1029-387, The Dow Chemical Company, Dow Chemical U.S.A., Specialty Chemical Department (1987
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$16.95more info
 
Sign InRegister
Username  
Password   
forgot password?